Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

403 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Global Variability in Administrative Approval Prescription Criteria for Biologic Therapy in Severe Asthma.
Porsbjerg CM, Menzies-Gow AN, Tran TN, Murray RB, Unni B, Audrey Ang SL, Alacqua M, Al-Ahmad M, Al-Lehebi R, Altraja A, Belevskiy AS, Björnsdóttir US, Bourdin A, Busby J, Canonica GW, Christoff GC, Cosio BG, Costello RW, FitzGerald JM, Fonseca JA, Hansen S, Heaney LG, Heffler E, Hew M, Iwanaga T, Jackson DJ, Kocks JWH, Kallieri M, Bruce Ko HK, Koh MS, Larenas-Linnemann D, Lehtimäki LA, Loukides S, Lugogo N, Maspero J, Papaioannou AI, Perez-de-Llano L, Pitrez PM, Popov TA, Rasmussen LM, Rhee CK, Sadatsafavi M, Schmid J, Siddiqui S, Taillé C, Taube C, Torres-Duque CA, Ulrik C, Upham JW, Wang E, Wechsler ME, Bulathsinhala L, Carter V, Chaudhry I, Eleangovan N, Hosseini N, Rowlands MA, Price DB, van Boven JFM. Porsbjerg CM, et al. Among authors: bourdin a. J Allergy Clin Immunol Pract. 2022 May;10(5):1202-1216.e23. doi: 10.1016/j.jaip.2021.12.027. Epub 2022 Jan 3. J Allergy Clin Immunol Pract. 2022. PMID: 34990866 Free article. Review.
Anti-interleukin-5 therapy in severe asthma.
Garcia G, Taillé C, Laveneziana P, Bourdin A, Chanez P, Humbert M. Garcia G, et al. Among authors: bourdin a. Eur Respir Rev. 2013 Sep 1;22(129):251-7. doi: 10.1183/09059180.00004013. Eur Respir Rev. 2013. PMID: 23997052 Free PMC article. Review.
Prognostic value of cluster analysis of severe asthma phenotypes.
Bourdin A, Molinari N, Vachier I, Varrin M, Marin G, Gamez AS, Paganin F, Chanez P. Bourdin A, et al. J Allergy Clin Immunol. 2014 Nov;134(5):1043-50. doi: 10.1016/j.jaci.2014.04.038. Epub 2014 Jun 27. J Allergy Clin Immunol. 2014. PMID: 24985405 Clinical Trial.
Mepolizumab treatment in patients with severe eosinophilic asthma.
Ortega HG, Liu MC, Pavord ID, Brusselle GG, FitzGerald JM, Chetta A, Humbert M, Katz LE, Keene ON, Yancey SW, Chanez P; MENSA Investigators. Ortega HG, et al. N Engl J Med. 2014 Sep 25;371(13):1198-207. doi: 10.1056/NEJMoa1403290. Epub 2014 Sep 8. N Engl J Med. 2014. PMID: 25199059 Free article. Clinical Trial.
[Biomarkers in asthma].
Taillé C, Bourdin A, Garcia G. Taillé C, et al. Among authors: bourdin a. Presse Med. 2016 Nov;45(11):1019-1029. doi: 10.1016/j.lpm.2016.04.021. Epub 2016 May 25. Presse Med. 2016. PMID: 27236617 Free article. Review. French.
Managing asthma in the era of biological therapies.
Bardin PG, Price D, Chanez P, Humbert M, Bourdin A. Bardin PG, et al. Among authors: bourdin a. Lancet Respir Med. 2017 May;5(5):376-378. doi: 10.1016/S2213-2600(17)30124-8. Epub 2017 Apr 24. Lancet Respir Med. 2017. PMID: 28463176 Free article. Review. No abstract available.
Oral Glucocorticoid-Sparing Effect of Benralizumab in Severe Asthma.
Nair P, Wenzel S, Rabe KF, Bourdin A, Lugogo NL, Kuna P, Barker P, Sproule S, Ponnarambil S, Goldman M; ZONDA Trial Investigators. Nair P, et al. Among authors: bourdin a. N Engl J Med. 2017 Jun 22;376(25):2448-2458. doi: 10.1056/NEJMoa1703501. Epub 2017 May 22. N Engl J Med. 2017. PMID: 28530840 Free article. Clinical Trial.
403 results